SAV1 and pancreatic ductal adenocarcinoma: Immunohistochemical analyses of pancreatic ductal adenocarcinoma showed that a low expression of the SAV1 protein was related to unfavorable clinicopathological features, such as histological differentiation and lymph node status [13].